SIGMAR1 and early-onset autosomal dominant Alzheimer disease: Pridopidine demonstrates neuroprotective effects, which are exquisitely mediated by activation of the SIGMAR1 in models of several neurological diseases including ALS, Huntington disease, Alzheimer disease and Parkinson disease [50–57].